Brian Furmanski
Company: Kriya Therapeutics
Job title: Chief Regulatory Officer
Bio:
Brian Furmanski is the Chief Regulatory Officer at Kriya. Prior to Bian was a Senior Clinical Pharmacology Reviewer at the FDA, investigator in the muscle metabolism and repair group at GlaxoSmithKline and started his career at Siga Technologies where he contributed to the development of novel antiviral therapies.
Seminars:
Defining the Role of Companion Diagnostics 1:10 pm
day: Day 2 REGULATORY PM
Mapping Out Key Regulatory Touchpoints 11:10 am
day: Day 2 REGULATORY AM
Leveraging a Safe Balance Between Efficacy and Toxicity in AAV products 11:30 am
Ensuring persistent gene expression and long-term efficacy of AAV drugs Strategies to minimize the toxicity of AAV therapies Discussing optimal dosage size and vector concentration to avoid toxicity complicationsRead more
day: Gene Therapy Beyond Rare Diseases Discussion Day